poisar

Stocks · News reference

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

Vandana Singh

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABTBBNXDXCMMMEDPODDTNDM
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Sns Insider

    Baby Food & Infant Formula Market Size to Reach USD 74.30 Billion by 2035 | Report by SNS Insider

    The global Baby Food and Infant Formula Market was valued at USD 40.37 billion in 2025 and is projected to reach USD 74.30 billion by 2035, growing at a CAGR of 6.29%. Growth is driven by urbanization, increasing parental health consciousness, demand for organic/premium products, and e-commerce expansion. However, recent product recalls by major manufacturers highlight safety concerns in the industry.

    ABTNSRGYDANOYKHC
  2. Researchandmarkets.Com

    Renal Denervation Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

    The global renal denervation market is expected to experience significant growth driven by rising resistant hypertension cases, positive clinical trial results, regulatory approvals, and technological advances in radiofrequency, ultrasound, and micro-infusion technologies. North America currently leads the market while Asia-Pacific is projected to grow fastest. The minimally invasive procedure treats uncontrolled hypertension by disrupting sympathetic nerves surrounding renal arteries.

    MDTBSXJNJABT
  3. Leo Sun

    If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio

    As concerns grow about a potential AI market slowdown due to inflation, rate hikes, and geopolitical tensions, investors should consider diversifying into dividend-focused ETFs like SCHD. The Schwab U.S. Dividend Equity ETF offers exposure to 100 stable, dividend-paying stocks across multiple sectors, providing a defensive hedge against AI stock volatility while delivering steady income and historical returns of 243% over the past decade.

    SCHDNVDAAVGOAMZNMRK
  4. Bbb National Programs

    National Advertising Division Finds Certain Kendamil Infant Formula Claims Supported; Recommends Others Be Modified or Discontinued

    The National Advertising Division ruled on a challenge by Abbott Laboratories against Kendamil infant formula. While NAD supported claims about whole milk ingredients, it recommended Kendamil discontinue or modify claims regarding nutritional superiority over competitors, breast milk comparisons, HMO immune health benefits, and brand heritage dating to 1962. Kendamil stated it will comply with NAD's recommendations.

    ABT